These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15983393)

  • 1. Improved survival for patients with follicular lymphoma.
    Lister TA
    J Clin Oncol; 2005 Aug; 23(22):4830-1. PubMed ID: 15983393
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients.
    Sacchi S; Pozzi S; Marcheselli L; Bari A; Luminari S; Angrilli F; Merli F; Vallisa D; Baldini L; Brugiatelli M;
    Cancer; 2007 May; 109(10):2077-82. PubMed ID: 17394190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding rituximab to cyclophosphamide, vincristine and prednisone increases time to treatment failure or progression in people with untreated stage III/IV follicular lymphoma.
    Ghielmini M
    Cancer Treat Rev; 2005 Dec; 31(8):644-7. PubMed ID: 16289339
    [No Abstract]   [Full Text] [Related]  

  • 4. New treatment options have changed the survival of patients with follicular lymphoma.
    Fisher RI; LeBlanc M; Press OW; Maloney DG; Unger JM; Miller TP
    J Clin Oncol; 2005 Nov; 23(33):8447-52. PubMed ID: 16230674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress in the therapeutic strategy for follicular lymphoma and mantle cell lymphoma].
    Ogura M
    Rinsho Ketsueki; 2006 Jun; 47(6):495-512. PubMed ID: 16862978
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary follicular lymphoma of the gastrointestinal tract: a retrospective case series.
    Kodama M; Kitadai Y; Shishido T; Shimamoto M; Fukumoto A; Masuda H; Tanaka S; Yoshihara M; Sakai A; Nakayama H; Chayama K
    Endoscopy; 2008 Apr; 40(4):343-6. PubMed ID: 18067068
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
    Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
    J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHOP chemotherapy followed by Rituximab consolidation as first line treatment in patients with follicular lymphoma. Long-term follow-up of a phase 2 trial.
    Jäger G; Quehenberger F; Linkesch W; Neumeister P
    Eur J Haematol; 2007 May; 78(5):453-5. PubMed ID: 17419745
    [No Abstract]   [Full Text] [Related]  

  • 9. Langerhans' cell histiocytosis mimicking relapse in a patient with follicular lymphoma.
    Gimeno E; Cervera M; Trampal C; Solano A; Villalba G; Serrano S; Besses C; Salar A
    Ann Hematol; 2008 Aug; 87(8):675-6. PubMed ID: 18351339
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrative tumor board: Recurrent lymphoma.
    Feng AY; Hallmeyer S; Peace D; Wunder J; Warber SL; Wilson M; Walker LG; Block KI
    Integr Cancer Ther; 2004 Sep; 3(3):238-56. PubMed ID: 15312265
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary multifocal non-Hodgkin lymphoma of the colon successfully treated with chemotherapy.
    Dalal L
    Gastrointest Endosc; 2008 Nov; 68(5):1005-6; discussion 1006. PubMed ID: 18565526
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.
    Liu Q; Fayad L; Cabanillas F; Hagemeister FB; Ayers GD; Hess M; Romaguera J; Rodriguez MA; Tsimberidou AM; Verstovsek S; Younes A; Pro B; Lee MS; Ayala A; McLaughlin P
    J Clin Oncol; 2006 Apr; 24(10):1582-9. PubMed ID: 16575009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular lymphoma--do no harm.
    Jones SE
    Cancer Treat Rep; 1986 Sep; 70(9):1055-8. PubMed ID: 3527406
    [No Abstract]   [Full Text] [Related]  

  • 14. High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.
    Canioni D; Salles G; Mounier N; Brousse N; Keuppens M; Morchhauser F; Lamy T; Sonet A; Rousselet MC; Foussard C; Xerri L
    J Clin Oncol; 2008 Jan; 26(3):440-6. PubMed ID: 18086798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma.
    Marcus R; Imrie K; Solal-Celigny P; Catalano JV; Dmoszynska A; Raposo JC; Offner FC; Gomez-Codina J; Belch A; Cunningham D; Wassner-Fritsch E; Stein G
    J Clin Oncol; 2008 Oct; 26(28):4579-86. PubMed ID: 18662969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy.
    Guadagnolo BA; Li S; Neuberg D; Ng A; Hua L; Silver B; Stevenson MA; Mauch P
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):928-34. PubMed ID: 16243446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'The sandwich sign' of mesenteric lymphoma.
    Hokama A; Nakamoto M; Kinjo F; Fujita J
    Eur J Haematol; 2006 Oct; 77(4):363-4. PubMed ID: 16856921
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
    Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
    Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Achieving Bcl-2/IgH negativity in peripheral blood/bone marrow after therapy implies better prognosis for patients with follicular lymphoma].
    Belada D; Smolej L; Stepánková P; Beránek M; Dvoráková D; Bukac J; Malý J
    Vnitr Lek; 2007 Oct; 53(10):1057-63. PubMed ID: 18072430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification updates and clinical investigations in indolent non-Hodgkin lymphoma.
    Cheson BD
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):4-6. PubMed ID: 18998258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.